CBmed GmbH
CBmed is a public-private partnership biomarker research center funded by the Austrian COMET program for excellent technologies. With its headquarters in Graz, Austria, CBmed has built a consortium including over 50 international partners in industry and academia on 4 continents worldwide.
Their vision to enable applied precision medicine – driven by scientific excellence and global partnerships for patient care and cure reflects their unique position at the interface of public health facilities, biobanks and services. This enables CBmed to pursue research activities for the development of cutting-edge individualized solutions to step outside of the current one-size-fits-all therapeutic models – bringing tailored and customized game-changing therapies for individual patients closer to fruition.